PSA vs SGHT · rev $1.23B vs rev $43.1M
PSA (PSA) versus Sight Sciences Inc (SGHT) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
Sight Sciences Inc (SGHT) is a medical devices company listed on NASDAQ.
Latest reported PSA revenue for 2026-06-30 was $1.23B. Net income was $500.0M. Revenue was up 1.2% from 2026-03-31 to 2026-06-30. PSA currently screens at market cap $0.
Latest reported SGHT revenue for 2026-06-30 was $43.1M. Net income was -$17.4M. SGHT currently screens at market cap $273.1M.
PSA currently screens at market cap $0. SGHT currently screens at market cap $273.1M.
Not investment advice. Open the PSA and SGHT stock pages for the full models.
Not investment advice.